David P. Schenkein - Insider Trading & Ownership

Entity
Individual
Location
C/O Bluebird Bio, Inc., 840 Memorial Drive, Cambridge, MA
Summary
The estimated net worth of David P. Schenkein is at least $11.7M dollars as of November 13, 2024. David P. Schenkein is the Director of AGIOS PHARMACEUTICALS, INC. and owns shares of AGIOS PHARMACEUTICALS, INC. (AGIO) stock worth about $10.1M. David P. Schenkein is the Director of Denali Therapeutics Inc. and owns shares of Denali Therapeutics Inc. (DNLI) stock worth about $1.33M. David P. Schenkein is the Director of REGENERON PHARMACEUTICALS, INC. and owns shares of REGENERON PHARMACEUTICALS, INC. (REGN) stock worth about $268K.
All Insider Reports
All Insider Reports

Ownership of David P. Schenkein

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AGIO AGIOS PHARMACEUTICALS, INC. Director $10.1M -$4.66M -31.5% Jun 20, 2024
DNLI Denali Therapeutics Inc. Director $1.33M -$1.93M -59.2% Nov 11, 2024
REGN REGENERON PHARMACEUTICALS, INC. Director $268K Jan 2, 2024
PRME Prime Medicine, Inc. Director Jun 12, 2024

Insider Transactions Reported by David P. Schenkein:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.